Discuss Study Endpoints Without Overreading Them

An endpoint can sound decisive until a clinician examines how it was defined and analyzed. A medical science liaison can support that examination by clarifying the scientific question, reviewing the source context, and naming limitations in the evidence. The exchange should not become a recommendation about what an individual patient should receive.

Ask which endpoint the clinician wants to discuss, whether they are comparing it with another study, and what aspect of the design is unclear. Use referenced approved information and distinguish a study observation from a clinical conclusion. Do not say an endpoint proves broad effectiveness, establishes individual benefit, or settles a treatment choice.

In a fictional meeting, an academic clinician asks, “This secondary endpoint was positive. Does that mean the intervention works for the patients I see?” The liaison responds, “We can look at how that endpoint was defined, the analysis plan, and the study population. Those details matter before drawing a broader conclusion. Which part of the paper would you like to start with?” The clinician asks about multiplicity and follow-up duration. The liaison provides the relevant source context.

Practice explaining an endpoint in plain language without adding a conclusion. Have a colleague press for a treatment answer that requires a simple yes or no. Review whether the liaison returns to the paper, states the evidence limit, and documents the requested references. The follow-up should support scientific review, document the requested references, and avoid treatment advice for an individual patient.